Replies to post #67633 on NanoViricides Inc. (NNVC)

[JG36]

Puffer, you seem to misunderstand why publishing peer reviewed results is necessary. It's not solely to increase the credibility of NNVC to outside investors (although that's certainly a very good reason in itself). Humans have an enormous capacity not only to fool each other but more importantly themselves. If you have a strong reason to want to believe something is true you focus upon the evidence that supports it and ignore the evidence that contradicts it. The scientific method is largely about how not to fool yourself and others. Under peer review people who don't have a vested interest in seeing NNVC succeed will be looking for flaws in the experiments or the analysis. If they don't find them, that's great. If they do, maybe the experiments can be done better. Or maybe Flucide isn't as effective as hoped. In any case, we're more likely to get at the truth, whatever it is, if peer review is used.

[Nanotoday]

So why spend millions in personal money on a manufacturing facility?
Diversification of assets and capital investment. Regardless of the success of the company, he will still own the facility. Also, significant positive tax implications.

And why add now to personal stock holdings that already reside in the 6 million share range (not including the 33M held through TheraCour)?
Just as insider selling caused the collapse of the SP, insider buying may help prop it up, making those shares already held by insiders significantly more valuable. Spend a little to make a lot.

And why would a group of Drs invest another $6M recently?
This is pretty much a no lose investment. As long as they can keep the company afloat, these investors will make their money back with profit.

These are concrete clues that should inform one's expectations on the forthcoming timeliness of tox and the cGMP facility.... and the ability to deliver, within reason, on the timelines recently given.
Concrete clues? Interesting choice of words. I'd prefer some concrete facts. There are many "concrete clues" that point to tox not being completed in '13 and the facility not being operational in time for Australia's flu season.

I dare say Diwan and these investors have a clearer view from their perch than you do.
I couldn't agree more. But that doesn't necessarily mean it will benefit the rest of us.

[Nanotoday]

Revised

http://www.nasdaq.com/symbol/nnvc/insider-trades

(look at the selling in '11)